Navigation Links
Graves' & Thyroid Disease National Patient Conference Set for San Diego, CA
Date:9/15/2008

BUFFALO, N.Y., Sept. 15 /PRNewswire-USNewswire/ -- Nancy Patterson Ph.D., Chair of the Graves' Disease Foundation announced it will hold its 2008 national Patient & Family Conference on October 17-19 at the Sheraton Resort in Carlsbad, California. The meeting is open to all patients and family members with Graves' disease or other thyroid gland disorders.

The leading cause of hyperthyroidism, Graves' disease represents a basic defect in the immune system, causing production of immunoglobulins (antibodies), which stimulate and attack the thyroid gland, causing growth of the gland and overproduction of thyroid hormone. Similar antibodies may also attack the tissues in the eye muscles and in the pretibial skin (the skin on the front of the lower leg). Graves' Disease affects two out of every 100 women but less common in men.

The Conference will focus on Graves' disease symptoms & treatment, hypothyroidism & hyperthyroidism, thyroid-related eye conditions; and an update on the latest Graves' disease research. Also workshops on the emotional and psychological impact of Graves' disease. You'll meet other patients coping with Graves' and thyroid-related illnesses.

Dr. Terry Smith, who is Chief Medical & Scientific Officer of the Graves' Disease Foundation and Professor of Medicine, at Harbor-UCLA Medical Center & The David Geffen School of Medicine at UCLA; is Conference Chair for this year's meeting.

Dr. Smith announced the following keynote physicians and renowned experts will speak at the Conference:

Raymond Douglas, MD

Jules Stein Eye Institute

Michael Kazim, MD

Columbia University, NY

Don O. Kikkawa, MD

Shiley Eye Center, La Jolla, CA.

Ira Lesser, MD

Harbor-UCLA Medical Ctr.

Some thyroid topics will be:

-- The Scientific basis for Graves' disease: how little we really know!

-- Medical & surgical approaches to hyperthyroidism

-- Modern approaches to double vision in Graves' ophthalmology

-- Bony decompression for Graves' opthalmopathy

-- The emotional impact of Graves' disease on patients and their families

-- The role of Steroids & Radiotherapy in Graves' opthalmopathy

-- New therapeutic approaches for Graves' disease on the horizon

For more Conference details, call the Graves' Disease Foundation's toll-free 1 (877) NGDF-123, or its website: http://www.NGDF.org.

Receive a free Graves' disease pamphlet or newsletter, send an email to: GravesEnewsletter@verizon.net.


'/>"/>
SOURCE Graves' Disease Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. PREOS(R) Granted U.S. Orphan Drug Status for Treatment of Hypoparathyroidism
2. Fluoride Damages the Thyroid, Report Shows
3. Thyroid Test Wont Help Pregnant Mom, Baby
4. Better detection accounts for increase in cases of thyroid cancer
5. Thyroid treatment no quick fix for weight loss in children
6. Early detection critical in treating pediatric thyroid cancer
7. Mailman School PH study finds increase in thyroid diseases risk from exposure at Chernobyl
8. Combination of Thyroid Medicines Not Necessary
9. Newly discovered role of thyroid hormone during pregnancy
10. Does artificial intelligence help clinicians to recognize atrophic gastritis with thyroid disease?
11. Thyroid Hormone Could One Day Treat Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... 23, 2017 , ... Rare Disease Report®, which is the ... Rare Disease Day events, hosted by the Rare Disease Legislative Advocates (RDLA) on ... weekly e-newsletter and quarterly publication, will be conducting interviews with patients and advocates ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rosica Communications, a ... content marketing, social media management, corporate communications, SEO and cause marketing, is opening ... in nearby New Hampshire, Massachusetts and Canada, Rosica will focus on expanding its ...
(Date:2/23/2017)... ... February 23, 2017 , ... Pink Pig Publishing ... generations converge and explore the world from different perspectives. By providing a place ... to gain understanding, increase empathy, and find greater happiness. , "Our approach ...
(Date:2/23/2017)... RI (PRWEB) , ... February 23, 2017 , ... ... today a new partnership with the Rhode Island Consortium for Autism Research and ... an opportunity for children with autism spectrum disorder (ASD) to see films in ...
(Date:2/23/2017)... York (PRWEB) , ... February 23, 2017 , ... Curemark, ... the safety and efficacy of CM-AT in children aged 3-8 with Autism, is now ... clinical sites already enrolling children across the United States. , “There are currently ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb 23, 2017 Research and Markets ... Analysis and Strategies - 2016" report to their offering. ... The latest research ... pricing data and benchmarks in the global Oesophageal Cancer market. ... What are the key drugs marketed for Oesophageal Cancer and ...
(Date:2/23/2017)... 2017 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ... and commercialization of innovative therapies for the treatment ... release fourth quarter and yearly financial results after ... management will host an investment-community conference call at ... on March 2 nd 2017 to discuss ...
(Date:2/23/2017)... , February 23, 2017 ... from increasing caseload for varicose veins in their body. ... globe are prompting the adoption of endovenous laser therapy ... global endovenous laser therapy market, published by ... of lifestyle choices and consequences of obesity have collectively ...
Breaking Medicine Technology: